221 related articles for article (PubMed ID: 2293503)
1. Transfusion-associated graft-versus-host disease.
Rappeport JM
Yale J Biol Med; 1990; 63(5):445-54. PubMed ID: 2293503
[TBL] [Abstract][Full Text] [Related]
2. Prevention of transfusion-associated graft-vs-host disease.
Holland PV
Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-associated graft-versus-host disease.
Rühl H; Bein G; Sachs UJ
Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Transfusion associated graft versus host disease.
Anwar M; Bhatti FA
J Ayub Med Coll Abbottabad; 2003; 15(3):56-8. PubMed ID: 14727344
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient.
Arsura EL; Bertelle A; Minkowitz S; Cunningham JN; Grob D
Arch Intern Med; 1988 Sep; 148(9):1941-4. PubMed ID: 3261972
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease: introduction and prospect.
Ohto H; Suzuki H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
10. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of transfusion-associated graft-versus-host disease.
Yasuda H; Ohto H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
[TBL] [Abstract][Full Text] [Related]
12. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis.
Sage D; Stanworth S; Turner D; Navarrete C
Transfus Med; 2005 Dec; 15(6):481-5. PubMed ID: 16359419
[TBL] [Abstract][Full Text] [Related]
14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
15. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
16. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation complicated by graft-versus-host disease and confounded by incidental transfusion-associated macrochimerism.
Pavenski K; Kamel-Reid S; Wei C; Cserti-Gazdewich CM
Transfusion; 2008 Oct; 48(10):2190-6. PubMed ID: 18631170
[TBL] [Abstract][Full Text] [Related]
18. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
20. Developments in the prevention of transfusion-associated graft-versus-host disease.
Fast LD
Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
